Clinical Trials on Stage 3 Age Related Macular Degeneration (AREDS Classification) in Hong Kong
Total 17 results
-
The University of Hong KongCompletedAge-Related Macular DegenerationHong Kong
-
Centre for Eye and Vision ResearchThe Hong Kong Polytechnic University; University of WaterlooRecruiting
-
The University of Hong KongThe Hong Kong Polytechnic University; The Hong Kong Society for the BlindRecruitingAge-Related Macular DegenerationHong Kong
-
Hoffmann-La RocheWithdrawnNeovascular Age-Related Macular DegenerationDenmark, Argentina, Hong Kong, Thailand, Portugal, Greece, Spain
-
Quark PharmaceuticalsPfizerCompletedAge Related Macular DegenerationSpain, Korea, Republic of, Turkey, Taiwan, United States, Israel, Austria, Philippines, Denmark, Hong Kong, India
-
VisionCare, Inc.Recruiting
-
AmgenParexelCompletedNeovascular (Wet) Age-related Macular Degeneration (AMD)Spain, United States, Czechia, Serbia, Israel, Canada, Germany, Japan, Hungary, Poland, Korea, Republic of, Estonia, Hong Kong, Italy, Latvia, Lithuania, Mexico, Slovakia
-
Outlook Therapeutics, Inc.RecruitingAge-Related Macular Degeneration | Wet Macular Degeneration | Neovascular Age-related Macular DegenerationUnited States
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
-
Shanghai Henlius BiotechActive, not recruitingA Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMDAge Related Macular DegenerationUnited States, Singapore, Spain, Germany, Slovakia, China, Hungary, Australia, Bulgaria, Poland, Latvia, Czechia, France, Italy, Serbia
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Polypoidal Choroidal VasculopathyJapan, Taiwan, Hong Kong, Singapore, Thailand, Korea, Republic of, Malaysia
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Opthea LimitedRecruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Malaysia, Poland, Spain, Thailand, Ukraine, United Kingdom
-
BayerTerminatedMacular DegenerationHong Kong, Korea, Republic of, United States, Canada, Switzerland, Spain, Japan, Italy, Czech Republic, Australia, Austria, Slovakia, Germany, Hungary, Israel, Chile, France, Colombia
-
Outlook Therapeutics, Inc.CompletedAge-related Macular Degeneration | Wet Macular Degeneration | Neovascular Age-related Macular DegenerationUnited States
-
Outlook Therapeutics, Inc.CompletedAge-related Macular Degeneration | Diabetic Macular Edema | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | BRVO - Branch Retinal Vein OcclusionUnited States
-
Novartis PharmaceuticalsCompletedDiabetic Macular Edema | Retinal Vein Occlusion | Wet Age Related Macular Degeneration | Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionSpain, China, Colombia, Korea, Republic of, Belgium, Greece, Japan, Russian Federation, Turkey, United Kingdom, Egypt, Germany, Australia, Canada, France, Austria, Hong Kong, Hungary, Israel, Netherlands, Peru, Singapore, Slovakia, Sl... and more